DC2706: 2026 Pacific Northwest Head & Neck Cancer Symposium

Saturday, October 10, 2026, 8:00 AM - 4:30 PM PT, Fred Hutchinson Cancer Center, Seattle, WA

AMA PRA Category 1 Credits™ (7.25 hours), IPCE (7.25 hours), Non-Physician (7.25 hours)

This symposium will review recent advances in the multidisciplinary management of head and neck cancers. Topics include emerging neoadjuvant and adjuvant immunotherapy data, updated radiotherapy approaches for salivary gland malignancies, new evidence in thyroid cancer management, and innovations in surgical ablation and reconstruction. The course aims to support evidence-based clinical decision-making and optimize patient care. 

Website Link

Contact Email

1. Explain recently published neoadjuvant and adjuvant immune checkpoint inhibitor trials and illustrate relevant clinical decision-making in selected mucosal and cutaneous squamous cell carcinoma patients.
2. Assess updates in the management of salivary gland cancers, including indications for proton and neutron radiotherapy.
3. Analyze recently-published studies in the management of well-differentiated and anaplastic thyroid cancers
4. Evaluate innovations in surgical ablation and reconstruction.
5. Manage implicit bias in the diagnosis and management of head and neck cancers.

This symposium will review recent advances in the multidisciplinary management of head and neck cancers.

Website Link

Contact Email

In support of improving patient care, the University of Washington School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Washington School of Medicine designates this Live Activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

“This activity was planned by and for the healthcare team, and learners will receive 7.25 Interprofessional Continuing Education (IPCE) credits for learning and change.”

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of an accredited activity, including faculty, planners, reviewers or others in control of content are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the start of the activity. All those in control of content have no financial relationships to disclose, unless otherwise listed.

Saturday, October 10, 2026